Fact CheckerSign in

NCT07624448Recruiting

Regulating Together for Intellectual Disability and Autism: A Group Behavioral Therapy for for Emotion Dysregulation

Adapting a Group Intervention for Emotion Dysregulation in Autism and Intellectual Disability

Source: ClinicalTrials.gov · Last updated 3 Sept 2026

Brief summary (registry, in English)

The goal of this study is to help children with autism and a co-occurring intellectual disability and their families learn practical strategies for managing issues like irritability, aggression, and other challenging behaviors. The main objective of this study is: To adapt current Regulating Together materials to create an outpatient group program for emotion dysregulation in autism and co-occurring intellectual disability (ASD + ID) that will improve psychosocial outcomes for youth with ASD + ID.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
10 (estimated)
First submitted
28 May 2026
Start date
Oct 2027
Primary completion date
Jun 2028
Lead sponsor
Children's Mercy Hospital Kansas City
Diseases
Autism
NCT number
NCT07624448

What you commit to

  • Study type: Interventional
  • Planned participants: 10
  • From Oct 2027 to the primary completion date, Jun 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Child Participant Inclusion Criteria:
  • Males, females, or non-binary youth between 8 and 12 years of age
  • Confirmed diagnosis of Autism Spectrum Disorder (ASD)
  • Confirmed diagnosis of Intellectual Disability
  • Fluent in spoken English.
  • Use of flexible phrase speech or greater
  • Meeting clinically significant emotion dysregulation criteria
  • Willing to participate in twice weekly 90-minute sessions
  • Family is willing to keep prescribed psychiatric medication and outside behavioral interventions stable
  • Parent, guardian, or legally authorized representative (LAR) must provide written permission on behalf of the participant
    • Child Participant Exclusion Criteria:
  • Initiation of new psychosocial intervention within 30 days prior to first day of treatment
  • Presence of physical aggression in the child directed towards a peer outside the home (i.e., non-siblings) that resulted in injury within 30 days prior to screening. Other significant disruptive, aggressive, self-injurious, or sexually inappropriate behavior felt to be dangerous or overly disruptive to the group sessions will be reviewed by the study team on an individual basis.
  • Presence of comorbid major neuropsychiatric illness warranting other treatment approaches
  • Presence of any major sensory impairment that would limit participating in the material including blindness or uncorrected hearing loss
    • Caregiver Inclusion Criteria:
  • Age ≥ 18 years
  • Lives and cares for their child with ASD+ID for \> 50% of the year
  • Fluent in spoken English.
  • Willing to participate in twice weekly 90-minute sessions, including one virtual session weekly
    • Caregiver Exclusion Criteria:
    • -Presence of any major sensory impairment that would limit participating in the material including blindness or uncorrected hearing loss

Age in the registry: 8 years to 12 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Children's Mercy
Coordinator of this site? Confirm its status
Kansas CityUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.